<DOC>
	<DOCNO>NCT00171340</DOCNO>
	<brief_summary>Post-menopausal breast cancer patient receive letrozole 2.5 mg daily treatment breast cancer randomize treatment group receive either upfront zoledronic acid 4 mg IV 15-minute infusion every 6 month delay start zoledronic acid 4 mg IV 15-minute infusion every 6 month . Delayed start zoledronic acid initiate either Bone Mineral Density T-score -2 Standard Deviations either lumbar spine hip clinical fracture unrelated trauma asymptomatic fracture discover month 36 schedule visit . Letrozole 2.5 mg give daily 5 year .</brief_summary>
	<brief_title>Zoledronic Acid Prevention Cancer Treatment Related Bone Loss Postmenopausal Women Receiving Letrozole Breast Cancer .</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Bone Diseases , Metabolic</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<mesh_term>Letrozole</mesh_term>
	<criteria>Stage IIIIa breast cancer Postmenopausal recently postmenopausal Recent surgery breast cancer Estrogen Receptor positive and/or progesterone receptor positive hormone receptor status No prior treatment letrozole Other protocoldefined inclusion criterion may apply . Metastatic disease Invasive bilateral disease Clinical radiological evidence exist fracture spine hip Prior treatment IV bisphosphonates past 12 month Current treatment oral bisphosphonates ( must discontinue within 3 week baseline evaluation ) Use Tibolone within 6 month Prior use parathyroid hormone 1 week Previous concomitant malignancy Abnormal renal function History disease effect bone metabolism Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Bone Loss</keyword>
	<keyword>Osteopenia</keyword>
	<keyword>Breast cancer</keyword>
	<keyword>letrozole</keyword>
	<keyword>zoledronic acid</keyword>
	<keyword>postmenopausal</keyword>
</DOC>